Overview

Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection

Status:
Not yet recruiting

Trial end date:
2024-02-24

Target enrollment:
0

Participant gender:
All

Summary

Endoscopic submucosal dissection (ESD) is a common procedure that requires a long procedural time. Procedure Sedation is commonly provided to alleviate patients' discomfort and facilitate the implementation of procedures. We conducted a prospective study to determine the effect of intravenous infusion of lidocaine in the cognitive domain of the postoperative quality of recovery scale on day 3 after ESD.

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Fujian Provincial Hospital

Treatments:

Dsuvia
Lidocaine
Propofol
Sufentanil

Criteria

Inclusion Criteria:

1. American Society of Anesthesiologists (ASA) classification I-III;

2. Scheduled for endoscopic colorectal mucosal dissection.

Exclusion Criteria:

1. Patient refuses to participate;

2. BMI greater than 30;

3. Allergic or contraindication to study drugs;

4. History of chronic pain and long-term use of analgesic medication;

5. Severe arrhythmia;

6. Hepatic and renal dysfunction;

7. Any other conditions precluded study inclusion, such as cognitive impairment,
pregnancy, or inability to communicate in Mandarin Chinese.